Taiwan FDA registration 7946f8a83414d898fd1bc588ea3f3e6c
Constant insulin growth factor binding protein-3
TW: 常盈類胰島素生長因子結合蛋白-3
Taiwan·Risk Class 2·IMMUNOTECH s.r.o.·Registered Feb 03, 2006 – Feb 03, 2016CancelledRegistration details
- Analysis ID
- 7946f8a83414d898fd1bc588ea3f3e6c
- Customs Code
- DHAS0601596001
Company information
- Manufacturer
- IMMUNOTECH s.r.o.
- Manufacturer Country
- Czechia
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Intended Use
- Radioimmunoassay quantification was used to detect IGF BP-3 pancreatic hormones in serum.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1370 Human Growth Hormone Testing System
- Import Information
- Consent must be attached to the import (with the consent of the Atomic Energy Commission must be obtained for each import); input
Dates and status
- Registration Date
- Feb 03, 2006
- Expiry Date
- Feb 03, 2016
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Constant insulin growth factor binding protein-3 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7946f8a83414d898fd1bc588ea3f3e6c and manufactured by IMMUNOTECH s.r.o.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices